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M A J O R A R T I C L E
Characterization of Viral Agents Causing Acute
Respiratory Infection in a San Francisco University
Medical Center Clinic during the Influenza Season
Janice K. Louie,1 Jill K. Hacker,2 Ralph Gonzales,3 Jennifer Mark,2 Judy H. Maselli,3 Shigeo Yagi,1
and W. Lawrence Drew4
1Viral and Rickettsial Disease Laboratory, California Department of Health Services, and 2California Emerging Infections Program, Richmond,
and 3Division of General Internal Medicine and 4Department of Laboratory Medicine, University of California, San Francisco
Background. With use of polymerase chain reaction (PCR) and a centrifugation-enhanced viral culture
method, we characterized the viruses causing acute respiratory infection in adults during an influenza season.
Methods. During January–March 2002, nasopharyngeal wash specimens from previously healthy adults pre-
senting with respiratory symptoms were evaluated for viral pathogens with centrifugation-enhanced viral culture
and PCR.
Results The diagnoses in 266 cases included unspecified upper respiratory infection (in 142 [54%] of the
cases), acute bronchitis (42 [16%]), sinusitis (23 [9%]), pharyngitis (22 [8%]), and pneumonia (17 [6%]). The
use of a shell vial assay and PCR identified a pathogen in 103 (39%) of the patients, including influenza A or B
in 54, picornavirus in 28 (including rhinovirus in 24), respiratory syncytial virus (RSV) in 12, human metapneu-
movirus in 4, human coronavirus OC43 in 2, adenovirus in 2, parainfluenza virus type 1 in 1, and coinfection
with influenza and parainfluenza virus type 1 in 2.
Conclusion. Our findings demonstrate that, even during the influenza season, rhinovirus and RSV are prevalent
and must be considered in the differential diagnosis of adult acute respiratory infection before prescribing antiviral
medication. Human coronavirus and human metapneumovirus did not play a substantial role. PCR was an especially
useful tool in the identification of influenza and other viral pathogens not easily detected by traditional testing
methods.
Community-acquired respiratory infections in adults
contribute substantially to morbidity and mortality. Al-
though often self-limited, these infections can lead to
lost days of work, increases in medical costs, severe
illness, and even death. Historically, the etiology of
acute respiratory illness (ARI) has been difficult to de-
fine. Although “no isolated pathogen” is a frequent
finding (found in up to 50% of cases), it likely repre-
sents viral pathogens that the diagnostic tests were un-
able to detect [1]. Although there can be frequent over-
lap, historically, rhinoviruses, human coronaviruses,
and adenoviruses have been commonly associated with
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upper respiratory tract infections (e.g., the common
cold, otitis media, and sinusitis), whereas influenza, re-
spiratory syncytial virus (RSV), and parainfluenza vi-
ruses are commonly found in cases of lower respiratory
tract infection (e.g., acute bronchitis, bronchiolitis, and
pneumonia) [2].
Although their use is limited primarily to reference
laboratories and research settings, new molecular di-
agnostic techniques may offer better sensitivity and
specificity for detection of respiratory agents than are
offered by current standard clinical methods (e.g., an-
tigen detection or isolation). In the past decade, PCR
technology has improved our understanding of the bur-
den of respiratory viruses that have traditionally been
difficult to detect by routine methods, such as human
metapneumovirus, rhinovirus, RSV, and human co-
ronavirus [3–12]. However, many studies employing
PCR techniques have tested for only a single or a limited
number of respiratory agents [3–9,13–15]. Others have
focused on specific populations (e.g., pediatric patients
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or elderly persons) or those with specific underlying illnesses
(e.g., adults with chronic lung disease) or have focused on
outbreak settings [1, 3, 10–14, 16, 17]. In this study, we used
centrifugation-enhanced viral culture (R-Mix Fresh Cells; Di-
agnostic Hybrids) and PCR techniques to test for respiratory
viruses in a previously healthy population of adults, with the
goals of, first, better characterizing the spectrum of viral agents
causing ARI, and second, comparing the sensitivity of newer
molecular techniques with that of conventional methods for
diagnosing viral respiratory pathogens.
METHODS
Study design. During January–March 2002, consecutive
adults aged 18 years and seeking care at the University of
California, San Francisco (UCSF) Acute Ambulatory Care
Clinic or Emergency Department with symptoms of an ARI
were eligible for participation. UCSF is a tertiary care university
hospital with a large associated primary care clinic. The UCSF
Acute Ambulatory Care Clinic is the primary referral clinic for
patients sent from the UCSF primary care clinic for evaluation
of nonurgent medical problems, whereas the Emergency De-
partment evaluates acutely ill patients. Symptoms of ARI were
defined as development of a new illness within the past 3 weeks
with cough, sinus pain, congestion, sore throat, or fever. Pa-
tients with the following noninfectious, self-reported conditions
were excluded: pregnancy, systemic inflammatory disorders
(e.g., rheumatoid arthritis, systemic lupus erythematosus, or
inflammatory bowel disease), coexistent infections, severe tissue
damage within the previous 7 days (e.g., trauma, surgery, or
burns), myocardial infarction or unstable angina, cancer (met-
astatic or untreated), and AIDS or other immunosuppressive
disorders.
Trained research assistants continuously reviewed triage
notes to identify potentially eligible patients. Once the patients
were identified, a standardized encounter form was used to
ascertain the patient’s age, race or ethnicity, underlying medical
conditions, and clinical signs and symptoms. Clinical diagnosis
was assigned by the evaluating clinician and was recorded in a
free text area of the form. Because the diagnoses depended on
the individual clinician’s judgment, diagnoses may not have
been mutually exclusive. Patients were subsequently evaluated
and were treated by the clinicians in the usual manner. Medical
record review was performed to ascertain vital signs, physical
examination findings, diagnoses, and treatments. Study patients
received a $10 gift certificate for their time. The study protocol
and procedures were reviewed and approved by the UCSF
Committee for Human Research.
Laboratory methods. At the time of enrollment, nasopha-
ryngeal wash specimens were obtained using 5 cc of normal
saline, placed in viral transport media, aliquoted into multiple
sterile tubes, and stored at 70 C. Collection of conventional
swab samples and routine testing for bacteria were not per-
formed, because the primary objective of the study was to
examine the frequency of pathogens that cause acute bronchitis.
Group A Streptococcus and encapsulated bacteria (e.g., Strep-
tococcus pneumoniae, Haemophilus influenza, and Moraxella cat-
tarhalis) are not thought to be common causes of acute bron-
chitis in adults without underlying lung disease [2].
Specimens were inoculated into duplicate R-Mix Fresh Cell
shell vial cultures with coverslips (Diagnostic Hybrids) and were
cultured at 37 C for 24 and 48 h. R-Mix Fresh Cells, a com-
bination of mink lung cells and human adenocarcinoma cells,
are more sensitive than conventional culture and have a rela-
tively rapid turnaround time [18]. At culture termination, cells
were scraped from coverslips and spotted onto multiwell slides,
air-dried, and fixed in methanol. Initially, all cell preparations
were stained by direct immunofluorescence assay using a
polyvalent antibody (Bartels-Trinity Biotechnology) directed
against 7 viruses (influenzas A and B, RSV, adenovirus, and
parainfluenza virus types 1–3). The duplicates of cultures with
positive results were stained using virus-specific monoclonal
antibodies.
Total nucleic acid was extracted from respiratory specimens
using the MasterPure Complete DNA and RNA Purification
Kit (Epicentre Technologies). Conventional 1-step RT-PCR as-
says were performed according to Erdman et al. [10], with
primers for adenovirus, influenza A and B, RSV, and parain-
fluenza virus types 1–3 [10]; parainfluenza virus type 4 [13];
human metapneumovirus [3]; human coronavirus OC43 and
229E forward primer [4]; human coronavirus 229E reverse
primer [7]; and picornavirus (inclusive of rhinovirus and en-
terovirus) (D. Erdman, personal communication). To differ-
entiate rhinovirus from enterovirus, a 2-step RT-PCR process
was modified from Kares et al. [19]. A real-time RT-PCR assay
was used to improve sensitivity for RSV [9]. To confirm con-
ventional RT-PCR findings for influenza A, a real-time RT-PCR
assay was used (S. Lindstrom, personal communication).
Data analysis. Univariate procedures were used to examine
the distribution of illness characteristics, physical examination
findings, and laboratory results. Statistical tests of comparison
included x2 tests for dichotomous variables, t tests for normally
distributed continuous variables, and Wilcoxon rank sum tests
for nonnormally distributed variables. All statistical analysis was
performed using SAS software (SAS Institute).
RESULTS
This study was performed during January–March 2002, in the
midst of peak influenza activity, as measured by regional trends
in outpatient visits for influenza-like illness, influenza-associ-
ated hospitalizations, and laboratory detections of influenza in
northern California [20].
A total of 408 patients in the UCSF Acute Ambulatory Care
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Table 1. Demographic and clinical characteristics and etiology of acute respiratory illness in 266 adults, by pathogen.
Variable
All
subjects Flu A or Ba Picornab RSV HMPV HCoV PIV-1a Adeno
No pathogen
identified
No. (%) of total subjects with
the specified pathogen 266 (100) 54 (20) 28 (10) 12 (5) 4 (2) 2 (1) 3 (0.1) 1 (0.1) 163 (60)
Age
Mean years (SD) 38.7 (15.1) 38.0 (13.9) 39.3 (16.4) 33.0 (9.3) 41.8 (11.5) 26 (0) 36.7 (15.0) 21 39.6 (15.8)
Median years (IQR) 34 (28–44) 35 (27–46) 37 (29.5–43) 30 (27–41) 42 (33–51) 26 (26–26) 29 (27–54) 21 34 (28–45)
Male sex 108 (41) 19 (36) 13 (46) 4 (36) 2 (50) 0 (0) 1 (33) 1 (100) 66 (41)
Ethnicity,c no. of subjects
White 148 28 16 10 2 0 3 0 93
Black 23 6 1 0 0 0 0 1 15
Hispanic 25 9 1 2 1 0 0 0 12
Asian 49 8 8 0 1 0 0 0 30
Other 20 3 2 0 0 2 0 0 11
Smoker 37 7 7 0 1 0 0 0 22
Received influenza vaccine,
no. of subjects 40 5 6 3 2 0 0 1 22
Chronic illness
Allergies 75 (28) 15 (28) 10 (36) 5 (42) 0 1 (50) 0 1 (100) 43 (27)
COPD 2 (1) 0 0 0 0 0 0 0 2 (1)
Heart disease 9 (3) 2 (4) 0 0 0 0 0 0 7 (4)
Liver disease 3 (1) 1 (2) 1 (4) 0 0 0 0 0 1 (1)
Diabetes 14 (5) 2 (4) 0 1 (8) 0 0 0 0 11 (7)
Cancer 5 (2) 2 (4) 0 0 0 0 0 1 (33) 3 (2)
Asthma 36 (14) 4 (7) 7 (25) 3 (25) 1 (25) 0 0 0 21 (13)
Clinician diagnosisd
Bronchitis 42 (16) 6 (12) 10 (38) 0 0 0 0 0 25 (16)
Pharyngitis 22 (8) 2 (4) 3 (12) 0 0 0 0 0 18 (11)
Pneumonia 17 (7) 4 (8) 0 1 (8) 1 (25) 0 0 0 11 (7)
Sinusitis 23 (9) 4 (8) 2 (8) 1 (8) 0 0 0 0 16 (10)
URI 142 (54) 34 (65)a 10 (38) 9 (75) 3 (75) 2 (100) 1 (100) 3 (100) 80 (50)
Other 15 (6) 2 (4) 1 (4) 1 (8) 0 0 0 0 11 (7)
Antibiotic treatment 89 (34) 18 (33) 12 (43) 3 (27) 3 (75) 1 (50) 0 0 53 (33)
Hospitalizatione 9 (4) 1 (2) 1 (4) 1 (11) 0 0 0 0 6 (4)
NOTE. Data are no. (%) of subjects with specified pathogen, unless otherwise specified. Specimens were tested with R-Mix shell vial assay (Diagnostic
Hybrids) and PCR. Flu, influenza; Picorna, picornavirus; RSV, respiratory syncytial virus; HMPV, human metapneumovirus, HCoV, human coronavirus; PIV-1,
parainfluenza virus type 1; Adeno, adenovirus; IQR, interquartile range; COPD, chronic obstructive pulmonary disease; URI, upper respiratory infection.
a There were 2 cases of coinfection, including 1 patient coinfected with influenza A and parainfluenza virus type 1 and 1 patient coinfected with influenza B
and parainfluenza virus type 1.
b Twenty-four cases were further classified as due to rhinovirus, and 4 cases were unable to be further classified.
c Data were available for only 265 cases.
d Data were available for only 261 cases.
e Data were available for only 223 cases.
Clinic and Emergency Room who were being evaluated for
acute respiratory symptoms were approached to enroll in the
study. Of these, 289 patients enrolled, 281 had clinical speci-
mens collected, and 266 had specimens suitable for diagnostic
testing (table 1). The mean and median ages of patients were
38.7 and 34 years, respectively. The mean and median durations
of illness were 7.0 and 5.0 days, respectively. Most patients were
previously healthy; the most common reported underlying
medical problems included hayfever or allergies (75 [28%] of
266 cases), asthma (36 [14%] of 266), and diabetes (14 [5%]
of 266). Nine patients (4%) were hospitalized.
The following diagnoses were assigned by the evaluating cli-
nician: nonspecific upper respiratory infection (142 [54%] of
266), bronchitis (42 [16%] of 266), sinusitis (23 [9%] of 266),
pharyngitis (22 [8%] of 266), and pneumonia (17 [7%] of 266)
(table 1). Among the 142 cases with a diagnosis of upper re-
spiratory infection, the most common agent was influenza
(found in 34 [24%] of the cases). Among the 42 patients with
a diagnosis of bronchitis, the most common agent was picor-
navirus (found in 10 [24%] of the patients; in 9 of these cases,
the agent was further classified as rhinovirus), followed by in-
fluenza (in 6 [14%] of the patients). For the small numbers of
cases of sinusitis, pharyngitis, and pneumonia, detected agents
are listed in table 1.
Using both PCR and the shell vial assay, a viral agent was
detected in a total of 103 (39%) of the cases (table 2). A virus
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Table 2. Comparison of centrifugation-enhanced viral culture
and PCR in the diagnosis of viral agents of acute respiratory
illness in 266 previously healthy adults.
Pathogen
No. (%) of subjects with
a positive result, by test
Overall
Enhanced
viral culturea PCR
Influenza A 49 26 (10)b 47 (18)
Influenza B 5 6 (2)c 5 (2)
Influenza (subtype not specified) … 6 (2) 0 (0)
Respiratory syncytial virus 12 12 (5) 12 (5)
Parainfluenza virus types 1–3 3 2 (1)d 1 (1)
Adenovirus 2 2 (1) 1 (1)
Picornavirus 28 … 28 (11)
Human metapneumovirus 4 … 4 (2)
Human coronavirus OC43 2 … 2 (1)
Human coronavirus 229E 0 … 0 (0)
Parainfluenza virus type 4 0 … 0 (0))
Overall 103 (39) 52 (20) 100 (38)
NOTE. Individual rows do not add up to column totals, because patients
with coinfection are included in multiple rows.
a Centrifugation-enhanced viral culture was performed with R-Mix Fresh
Cells (Diagnostic Hybrids).
b One patient was coinfected with influenza A and parainfluenza virus type 1.
c One patient was coinfected with influenza B and parainfluenza virus type 1.
d Both patients had evidence of dual infection; one with influenza A and the
other with influenza B.
was detected by the shell vial assay in 52 (20%) of 266 patients,
whereas PCR identified a virus in 100 (38%) of the patients.
Of note, PCR identified 38% more influenza cases than did the
shell vial assay. Specific, targeted PCR identified additional vi-
ruses not assessed by the shell vial assay, including picornavirus
(28 cases), human metapneumovirus (4), and human coro-
navirus OC43 (2). Of the 28 cases of picornavirus infection,
additional PCR testing differentiated 24 as due to rhinovirus;
the other 4 picornaviruses could not be classified further on
the basis of the sensitivity of the assay.
Compared with the shell vial assay, PCR identified additional
cases of influenza A (17 cases) and parainfluenza virus type 1
(1 case) in patients who had negative results according to the
shell vial assay but failed to detect 5 cases in patients who had
positive results according to the shell vial assay (influenza A in
2 patients, adenovirus in 1 patient, and the parainfluenza virus
type 1 infections in 2 patients with influenza). Disparity in
influenza subtype was seen in 6 cases: the shell vial assay could
not distinguish between influenzas A and B in 5 cases and
identified influenza B in 1 case that was typed as influenza A
according to 2 different PCR methods.
Using the shell vial assay as a gold standard, the conventional
influenza A RT-PCR assay showed sensitivity, specificity, and
positive and negative predictive values of 94%, 93%, 64%, and
99%, respectively. A second RT-PCR assay for influenza A
showed concordance with these 17 PCR-positive, shell vial as-
say–negative samples. When these 17 samples were considered
true positives, the values increased to 96%, 100%, 100%, and
99%, respectively.
Clinical signs and symptoms for the 3 most common viral
pathogens are listed in table 3. When comparing patients in-
fected with influenza with those infected with rhinovirus or
RSV, patients with influenza were more likely to have myalgias
( ). Patients with influenza were more likely to have fever,P ! .05
compared with patients with rhinovirus ( ). There was aP ! .05
trend toward an association with fever and RSV ( );Pp .054
however, the small number of patients in the RSV group
( ) limited our power to detect a significant difference.np 12
Patients infected with rhinovirus or RSV were more likely to
have wheezing at examination than were others ( ).P ! .05
DISCUSSION
In this study, applying comprehensive diagnostic testing en-
abled identification of a viral agent in almost 40% of previously
healthy adults who presented for evaluation of ARI. Influenza
accounted for more than one-half of the pathogens identified.
Other frequently detected pathogens included picornavirus
(most of which were confirmed to be rhinovirus), which com-
prised one-quarter of identified etiologies, and RSV.
Our detection rate of almost 40% by PCR is somewhat
greater than that found in similar studies that have attempted
to determine the etiology of viral ARI in healthy adults using
nonmolecular methods. The Tecumseh study, a large longitu-
dinal prospective study of community ARI that was begun in
1965, detected a viral agent by isolation in !20% of adults 120
years old [21]. Another early study of upper respiratory infec-
tion involving 221 adults identified a viral etiology with use of
isolation methods in 34% of the patients [22]. With use of a
combination of isolation and serological testing, a study in-
volving 278 college students with respiratory symptoms found
an etiology in 32% of the patients [23]. A later study of adult
ARI that used a combination of culture, ELISA, and immu-
nostaining techniques yielded a viral etiology in 25% of patients
aged 15–24 years and in 35% of patients aged 25–65 years [24].
The improved detection rate of PCR for specific individual
respiratory agents (e.g., rhinovirus, enterovirus, human coro-
navirus, and parainfluenza virus) has been shown by others,
but our study is one of the few to compare PCR with non-
molecular methods for a broad array of pathogens [1, 3, 4, 6,
13, 16].
In our study, PCR was substantially more sensitive than iso-
lation or shell vial techniques for detecting influenza and iden-
tified almost 40% more cases than did the shell vial assay. PCR
gave no advantage over the shell vial assay for detection of RSV,
influenza B, adenovirus, or parainfluenza virus type 1 in our
population. However, PCR was especially useful in identifying
pathogens that frequently are not detected with conventional
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Table 3. Comparison of clinical characteristics among adult patients with acute
respiratory illness infected with influenza, picornavirus, and respiratory syncytial
virus.
Clinical characteristic
No. (%) of patients, by pathogen
P
Flu A or B
(n p 54)
Picornavirus
(n p 28)
RSV
(n p 12)
Temperature 138.0C 14 (26) 0 0 !.05a,b
Headache 43 (80) 19 (68) 9 (75)
Myalgias 45 (83) 13 (46) 6 (50) !.05a,b
Sore throat 38 (70) 18 (64) 11 (92)
Runny nose 45 (83) 24 (86) 11 (92)
Abnormal tympanic membrane 9 (17) 4 (14) 2 (18)
Sinus tenderness 8 (15) 4 (14) 1 (9)
Tonsillar swelling 5 (9) 4 (14) 2 (17)
Tonsillar exudates 3 (6) 2 (7) 0
Cough 52 (96) 26 (93) 12 (100)
Lymphadenopathy 13 (25) 5 (18) 4 (33)
Wheezing at examination 7 (13) 12 (43) 5 (42) !.05a,b
Shortness of breath 32 (59) 15 (54) 4 (33)
Chest pain 19 (35) 12 (43) 5 (42)
Nausea/vomiting 6 (11) 5 (18) 1 (8)
Diarrhea 8 (15) 3 (11) 0
Underlying medical condition(s)
Hayfever/allergy 15 (28) 10 (36) 5 (42)
Asthma 4 (7) 7 (25) 3 (25) !.05a
Other 6 (11 ) 1 (4) 1 (8)
Clinical course
Received antibiotics 18 (33) 12 (43) 3 (27)
Duration of illness, days
Mean (SD) 5.0 (4.7) 6.6 (5.5) 3.7 (1.2)
Median (25th–75th
percentile)
4 (3–5) 5 (3–8) 3.5 (3–4.5)
NOTE. There was a trend toward an association with fever and RSV when compared to
influenza ( ); however, the small number of patients in the RSV group (n p 12) limitedPp .054
our power to detect a significant difference. Flu, influenza; RSV, respiratory syncytial virus; TM,
tympanic membrane.
a Influenza A or B versus picornavirus.
b Influenza A or B versus RSV.
diagnostic techniques, including rhinovirus, human metapneu-
movirus, and human coronavirus.
For example, rhinovirus has not traditionally been consid-
ered an important “winter” pathogen. Early epidemiologic
studies demonstrated a distinct seasonality to rhinovirus in-
fection, with high incidences occurring in the fall and spring
in temperate regions; the major peaks in the fall were presumed
to be a result of children returning to school [25–27]. Studies
conducted in the winter months and specifically focusing on
adults have also found a low prevalence of ARI caused by
rhinovirus [22–24]. These studies relied on culture-based meth-
ods and may have underestimated true rates of infection. How-
ever, more recent studies using PCR have also identified high
incidences of rhinovirus infection in the spring and fall, when
rhinovirus can account for as much as 80% of ARI in healthy
adults, and much lower prevalences of rhinovirus infection (up
to 4%) in the winter months [1, 23, 28–30]. In contrast, 10%
of the patients in our study were infected with rhinovirus,
suggesting that rhinoviruses cause more cases of ARI during
the influenza season than has previously been suspected.
Likewise, RSV was a frequent finding in this population.
Historically, RSV has been considered a respiratory pathogen
primarily found in children and responsible for increased rates
of bronchiolitis and pneumonia during the winter months [5].
This perception may, in part, be due to higher viral shedding
in the nasal secretions of children, compared with those of
adults, thus facilitating detection in children. Recent studies
have recognized the importance of RSV in the elderly popu-
lation, in adults with underlying malignancy and cardiopul-
monary disease, and as a cause of nosocomial infections [31].
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Our results concur with those of other studies identifying RSV
as an important cause of ARI in previously healthy adults,
including a PCR-based study that identified RSV as a cause of
up to 20% of cases of influenza-like illness [5, 32].
The negative findings in our study—which occurred despite
our use of sensitive, targeted PCR testing—are worth noting.
The infrequent detection of human coronavirus in our study
is somewhat surprising. Older studies, based mostly on sero-
logic testing, estimated that human coronaviruses account for
up to 35% of cases of upper respiratory illness, with infrequent
case reports describing severe disease in infants, in the elderly
population, and in adults with chronic pulmonary disease [33].
Recent studies utilizing PCR have confirmed that human co-
ronavirus can play an important role in asthma exacerbations
in adults and in respiratory outbreaks; however, we were unable
to confirm that human coronavirus contributes substantially
to clinically significant ARI in healthy adults [16, 17].
Human metapneumovirus was also infrequently identified.
Although human metapneumovirus was only recently discov-
ered, evidence suggests that the virus has been circulating in
humans for several decades and has epidemiologic and clinical
characteristics similar to those of RSV [34]. To date, little is
known about the contribution of human metapneumovirus to
ARI in adults; limited data estimate human metapneumovirus
prevalence among nonhospitalized individuals at 1%–9% [3,
15, 34]. Employing the same primers as other investigators, we
identified human metapneumovirus in only 1% of cases. Our
results agree with existing data suggesting that human metap-
neumovirus can cocirculate at the same time as influenza and
that it is an infrequent cause of ARI in healthy young adults.
The limitations of PCR testing should be noted. In this study,
the specimens tested by PCR underwent multiple freeze/thaw
cycles, which may have adversely affected assay sensitivity. Un-
like standard culture methods, PCR limits detection to the
targeted agents, and the sensitivity and specificity of individual
PCR tests may vary depending on the target pathogen and the
specific primers and probes used. It is possible that samples
with positive PCR results but negative shell vial assay results
may represent false positives; however, in this study, the PCR
test results were corroborated with concurrent conventional
testing or with a second RT-PCR assay. In addition, previous
non–culture confirmed positive PCR results in our laboratory
have been confirmed by product sequencing [35].
Our findings have important clinical implications. Early
studies established a correlation between circulation of influ-
enza virus in the community and concurrent increases in the
incidence of severe ARI, hospitalizations for pneumonia, and
influenza-associated mortality [36]. This led some to conclude
that, when influenza is circulating within the community, pa-
tients with specific clinical signs and symptoms (e.g., cough
and fever within 48 h after onset of symptoms) are likely to
have influenza and may benefit from empiric antiviral therapy
to reduce the duration of illness and the number of influenza-
associated hospitalizations [37–39]. However, these recom-
mendations are based on retrospective pooled analysis of an-
tiviral clinical trials, in which the inclusion criteria required
presence of fever and/or symptom of fever, which may have
conferred a selection bias. In our study, the major clinical dif-
ferences among the most common agents—influenza, rhino-
virus, and RSV—were the presence of myalgias with influenza
and fever with influenza and RSV. A finding of wheezing on
examination was associated with rhinovirus or RSV infection.
The association of wheezing with both rhinovirus and RSV
infection has been described and has been postulated to be due
to increased bronchial reactivity caused by airway injury, di-
minished b-adrenergic function, IgE production, and enhanced
leukocyte histamine release [40]. When assessing patients with
nonspecific symptoms of influenza-like illness, these additional
clinical clues may be of use to the clinician considering the
benefits and drawbacks of prescribing antiviral therapy, which
can be expensive or may have associated adverse effects. For
example, the adamantane drugs are associated with CNS-related
adverse events, particularly in the elderly population, and os-
eltamivir can cause adverse gastrointestinal effects [34].
In conclusion, our findings demonstrate that, even during
the influenza season, rhinovirus and RSV are prevalent and
must be considered in the differential diagnosis of adult ARI
before prescribing antiviral medication. Human coronavirus
and human metapneumovirus did not appear to play a sub-
stantial role. Finally, PCR was an especially useful tool in the
identification of influenza and other viral pathogens not easily
detected by traditional testing methods.
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